Astellas Pharma is a major Japanese drugmaker in oncology and urology with a growing cell/gene-therapy and eye-disease pipeline. It trades on the Tokyo Stock Exchange under code 4503, in the Pharmaceuticals sector.
Key Facts
| Item | Details |
|---|---|
| Ticker | 4503 |
| Exchange | Tokyo Stock Exchange (TYO: 4503) |
| Sector | Pharmaceuticals |
| Headquarters | Tokyo, Japan |
Bull Case & Risks
Bull Case
- A diversified drug portfolio
- New growth drugs (e.g., Veozah, Padcev)
- A global commercial reach
Risks
- Key patent cliffs
- Pipeline and pricing risk
Outlook
Astellas is a global Japanese pharma managing patent cliffs while building new oncology and specialty franchises.
Educational information only, not investment advice. Stocks carry risk including possible loss of principal; past performance does not guarantee future results.